Navigation Links
Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
Date:5/8/2009

awn from the study.

About the ROADMAP One-Year Results

According to baseline blood pressures of the overall patient population, patients were categorized into the following JNC 7 classifications: normal, pre-hypertension, Stage 1 and Stage 2 hypertension. Mean BP for the overall population at study randomization was 136.2/80.6 mm Hg. In the 4,013 patients who remained on double-blind treatment with either olmesartan medoxomil therapy or placebo after one year, mean systolic BP reduction was 9.4 mm Hg, though responses were highly dependent on JNC 7 stages at outset. The ROADMAP study also showed a decrease in the prevalence of Stage 1 hypertension from 32 to 11 percent, as well as decrease in the prevalence of Stage 2 hypertension from 9 to 2 percent. In addition, the prevalence of normotension increased from 11 to 22 percent.

About Diabetes, Microalbuminuria and Hypertension

According to the World Health Organization (WHO), the number of people who have diabetes worldwide was approximately 170 million people in 2000, with that number anticipated to more than double by the year 2030.(2) Accounting for about 90 percent of diabetes cases worldwide, type 2 diabetes results from the body's inability to respond properly to the action of insulin produced by the pancreas.(3)

Diabetes is among the leading causes of kidney failure.(4) High blood sugar levels and high blood pressure (often present in patients with type 2 diabetes), may result in small amounts of albumin, a plasma protein, leaking into the urine. This microalbuminuria is an early sign of kidney dysfunction, and is a strong independent risk factor for cardiovascular disease.(5)

Hypertension, or high blood pressure, is a major factor for the development and acceleration of kidney disease in people with diabetes.(6) The JNC 7, American Diabetes Association (ADA), the American Society of Hypertension (ASH) and the E
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation
4. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
5. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
6. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
7. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
8. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
9. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
10. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
11. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  American Laboratory Trading, ... in North America, has named industry veteran Anggie Becorest ... Development. Becorest will be based out of the company,s ... role will include expanding the company,s west coast operations, ... opportunities. "ALT has been the leader in ...
(Date:5/5/2015)... Calif., May 5, 2015 Isis Pharmaceuticals, Inc. ... income of $4.0 million for the three months ended ... operating loss of $22.6 million for the same period ... to higher revenue from milestone payments earned from its ... a GAAP basis, Isis reported a loss from operations ...
(Date:5/5/2015)... Scientific Corporation (NASDAQ: KEQU ) announced today the election ... of Directors, effective April 29, 2015. Mr. Gehl is a ... The election of Mr. Gehl is in conjunction with ... his intention to resign from the Board, effective May 29, ... Mr. Gehl was also elected chair of the Audit Committee, ...
Breaking Medicine Technology:ALT Names Anggie Becorest Senior Vice President of Business Development 2Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 13Keith M. Gehl Elected to Kewaunee Scientific Board of Directors 2Keith M. Gehl Elected to Kewaunee Scientific Board of Directors 3
... Findings Show Survival Improvement with Lower Doses ... and other,Drugs in Newly Diagnosed Myeloma -, ... -- The,International Myeloma Foundation (IMF) - supporting ... myeloma patients,families, researchers and physicians - today ...
... April 5, 2007-- Stent thrombosis,restenosis and lifelong prescriptions. ... used as part of their heart,operations may be ... than medical experts have ever publicly acknowledged. Recent,articles ... drug-eluting stents continue to take blood thinners, they,could ...
Cached Medicine Technology:The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2
(Date:5/5/2015)... (PRWEB) May 05, 2015 Major League ... with the belief that ultimate Frisbee™ is home to ... next sport that engages the world. Nike Ultimate Camps’ ... by creating opportunities for young athletes to learn about ... with MLU the perfect fit. , The Nike Ultimate ...
(Date:5/5/2015)... 05, 2015 Igantia , an ... leads an international initiative to examine key biological milestones ... human lifespan. Scientists at Igantia believe that better ... the initiation of her menstrual cycle to her transition ... aging and, ultimately, extend the lifespan. , By ...
(Date:5/5/2015)... May 05, 2015 After record-breaking sales ... in 2014, Walgreens introduces the Cookies & Cream flavor ... innovation, Extend Nutrition has continually raised the bar for ... taste, combined with an unprecedented nutritional profile, backed by ... success, Extend Nutrition will launch additional new products and ...
(Date:5/5/2015)... Kan. (PRWEB) May 05, 2015 B. ... exclusively to healthcare providers, has been retained to recruit ... in Helena, Mont. The top executive search firm in ... more than 900 healthcare executives into organizations. , Shodair ... treatment facility in Montana to offer both acute and ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Atlantic ... Week, AIS’s Directory of Health Plans, and other ... announce its new monthly newsletter, AIS’s Value-Based Care ... systems, physician groups, pharma companies and their advisers, ... (ACOs), medical homes, bundled payments, coordinated care, global ...
Breaking Medicine News(10 mins):Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 2Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 3Health News:New AIS Newsletter Features Expert Insights and Strategies on Value-Based Care Arrangements 2
... , , LOS ANGELES, Oct. 9 ... 24th was a smashing success for the retailer known as ... tastemakers and Torrid fans packed the courtyard at the Fashion ... Runway--to celebrate fashion, honor people who work to motivate women ...
... Society of Hematology (ASH) is proud to announce ... Program, which builds hematologic capacity in developing countries. ... developing countries receive valuable clinical, laboratory, or technological ... institution under the mentorship of an ASH member ...
... Supplements help fight treatment-related bone loss, researchers say , FRIDAY, ... low levels of vitamin D, which could lead to weaker ... recommend high doses of vitamin D for them. , "Vitamin ... breast cancer have accelerated bone loss due to the nature ...
... Inc., (Pink Sheets: USFM) a diversified supplier of Farming, Nursery ... companies, Aloe Vera based Health & Beauty products can now ... websites in the world. US Farms, Inc. would like its ... Aloe365 line of Aloe Vera Juice and Skin Gel products ...
... Oct. 9 Enjoy a peaceful night,s sleep ... your partner,s incessant snoring with the Brookstone® ... and product development company recently launched its anti-snore ... helpful in reducing snoring and providing comfort without ...
... Oct. 9 The Costa Atlantica, a member of the Costa ... in a recent inspection conducted by the Centers for Disease Control ... during a stopover in New York, one of the port calls ... cruise. The cruise departed on September 16 from Savona and ended ...
Cached Medicine News:Health News:Torrid's Model Search Winners, Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 2Health News:Medical professionals from developing nations to pursue hematology training 2Health News:Vitamin D Good for Breast Cancer Patients 2Health News:US Farms, Inc. Aloe Vera Products Now Available on eBay 2Health News:US Farms, Inc. Aloe Vera Products Now Available on eBay 3Health News:Rest Assured With Clinically Tested Anti-Snore Pillow 2Health News:Costa Atlantica Receives a Perfect Score for Vessel Sanitation 2Health News:Costa Atlantica Receives a Perfect Score for Vessel Sanitation 3
... Durable ergonomic chairs with concave seats ... • Select options like seats, backrests, ... Choose the BE Series for top ... including: industry, education, laboratory, clean room, ...
... ergonomic chairs with concave seats and large ... like seats, backrests, armrests, and casters and ... top performance in a variety of environments ... control, health care and office. • With ...
... Durable ergonomic chairs with concave seats and ... options like seats, backrests, armrests, and casters ... for top performance in a variety of ... static control, health care and office. • ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
Medicine Products: